Back to Authors

Waggoner, Steven

https://orcid.org/0000-0001-7037-4858

A5044100563 | I2799343972

Mayo Clinic

University Hospitals of Cleveland

Citations 2

Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma

JAMA Oncology | June 13, 2019 | Volume: 5 | Issue: 8 | Pages: 1141

10.1001/jamaoncol.2019.1048 | PMID 31194228

TOPACIO/Keynote-162 (NCT02657889): A phase 1/2 study of niraparib + pembrolizumab in patients (pts) with advanced triple-negative breast cancer or recurrent ovarian cancer (ROC)—Results from ROC cohort.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 106-106

10.1200/jco.2018.36.15_suppl.106